Vasileios D.

Background

About Vasileios D.

I am a MedTech innovator and AI scientist dedicated to transforming acute care through intelligent, clinically validated decision-support systems. With a PhD in Neuroscience from ETH Zurich and University Hospital Zurich and a career spanning AI engineering at CERN, IBM, and more, I bring deep expertise in predictive modeling, digital patient twins, and scalable health data integration. As Co‑Founder and Chief Scientific Officer of Aisthesis Medical, I lead the scientific and regulatory strategy behind VIOSync, an AI-powered software-as-a-medical-device (SaMD) that predicts sepsis and patient deterioration up to 48 hours in advance. Our work bridges cutting-edge machine learning with MDR- and FDA-compliant clinical validation, delivering explainable, actionable insights for hospitals. My core strengths include- AI & Data Science Leadership – designing, validating, and deploying predictive models in high-stakes clinical environments- Regulatory & Clinical Expertise – navigating MDR/FDA pathways for SaMD, leading multi-site clinical validations, and ensuring safety and performance compliance- Strategic Innovation – building and scaling MedTech solutions from concept to market, driving hospital partnerships, grant funding, and investor engagement- Cross-Disciplinary Collaboration – uniting clinicians, engineers, and regulatory experts to deliver impactful healthcare technologies- Scientific Excellence & Rigor – conducting high-impact research, publishing in peer-reviewed journals, and ensuring robust evidence generation for clinical and regulatory acceptance. I thrive at the intersection of AI, clinical medicine, and regulatory science, building technologies that are not only innovative but also safe, trustworthy, and globally scalable. My focus is on bringing next-generation digital health solutions from concept to bedside—improving patient outcomes while shaping the future of data-driven medicine. Currently, I’m driving multi-site clinical validation studies across Europe, the UK, and the US, strategic partnerships with leading hospitals and regulatory bodies, and advancing MedTech innovation for acute care. Let’s connect if you’re passionate about AI in healthcare, SaMD regulation, or building the next wave of transformative medical technologies.